kitozyme

Our products are supported with safety reports, third part certificates(ISO 9001 & COSHER & GAP & HALAL & ORGANIC), clinical data(from customers), professional essays and TCM theories. The key to our service is to set realistic customer expectations, and then not to just meet them, but to exceed them-preferably in unexpected and helpful ways. With the mission: To make everybody healthier by natural ingredients, Chibio Biotech, as one biotechnology company integrating science industry and trade, has been focused on R&D and production of high-end plant-based and 100% natural ingredients with commercial potentiality for over 8 years. We have been manufacturing and selling vegetal chitosan since establishment. And we're honored to cooperate with many TOP 500 companies for years. To ensure the high quality of products, we take strict control of each process, from the raw materials to the production. With passion & mission: to make everybody healthier with natural ingredients, we will do our jobs so well that you will want to see it again and bring your friends. Brand Manufacturers & Contract Manufacturers of Health & Dietary & Food Supplements​.

ChiPro works with Chitosan, Chitosan products, and other natural substances. ChiPro’s Chitosanhydrochlorid, ChiProPlant, is registered as Basic Substance and is applied in agriculture. In addition, we are involved in international research projects with life-sciences orientation and often function as a link in technology transfer. Besides, we have a record of 20 years in international consultancy and work on innovative products in various life science projects. For 20 years, we have advised national and international companies and (governmental) institutions in product-, value chain-, and export development, often on behalf of German and other European governmental organizations.

Our products are especially designed for advanced applications, particularly those using MALDI-Glycan Mass Spectrometry Spatial Imaging, UPLC/HPLC, and Hydrophilic Interaction Chromatography (HILIC). That’s why we are the leading choice for a variety of industry applications including Pharmaceuticals, Diagnostics, Drug Discovery and Biologics, just to name a few. We are trusted by large scale companies in a variety of industries ranging from pharmaceutical brands to diagnostic companies. Currently, our products can be purchased directly from our valued distributors located in North America, Europe and Asia. N-Zyme Scientifics is a leading resource for MS-based spatial glycan tissue imaging and any other application that requires highly active and stable endoglycosidases. N-Zyme Scientifics is a development and supply company located at the Pennsylvania Biotechnology Center of Bucks County, one of the premier Biotechnology Centers in the Country. We specialize in enzymes used in Glycobiology-based applications and research in Pharmaceuticals, Diagnostics, Drug Discovery and Biologics. No matter what type of enzyme you need, our team at N-Zyme Scientifics can provide you with the best quality products on the market today.

Its daughter company Chitinor AS has established comprehensive know-how on extraction and processing of bio-actives from the Atlantic Ocean. Our products are produced from pure Norwegian shrimp shells that are sourced from sustainable fishing in the cold waters of the North Atlantic Ocean and processed in local, fully-automated peeling factories. Chitinor AS contributes to reducing pollution of the environment by utilizing the by-products of the fishing industry. Our products are analyzed according to the USP/NF Monograph. Chitinor AS uses exclusively fresh Norwegian shrimp shells derived from the cold waters of the North Atlantic Ocean for the production of its pure and natural chitosans. Chitinor AS – A Company in the Seagarden Group. Chitinor AS manufactures products with controlled and stable quality. The Seagarden Group is a Norwegian company supplying 100% natural marine products to global markets.

Karamedica’s driving goal is to expand medical and veterinary uses of biopolymer-based products, especially those containing chitosan, by developing novel decontamination processes like non-thermal plasmas. Karamedica also seeks to create innovative medical devices and drug delivery systems based on these biopolymers. Karamedica’s founders have developed and patented non-thermal atmospheric pressure nitrogen plasma technology for decontamination of delicate biomaterials, like chitosan. Karamedica’s technology overcomes this barrier, which will allow chitosan to be used in a wide-variety of medical applications. Karamedica is focused on developing chitosan for clinical use as an implantable hemostatic device for controlling bleeding during surgery and a drug delivery vehicle for both superficial bladder cancer and cerebral amyloid angiopathy (CAA). Karamedica’s implantable hemostatic device stops intraoperative bleeding and is resorbed by the body, much like resorbable sutures are resorbed over time. Andrew Crofton is a founder and a member of the board of directors of Karamedica. Crofton is the co-inventor on 5 patents or pending patents related to chitosan and Alzheimer’s disease.

Enzymit is changing the paradigm with its cell-free enzymatic approach to manufacturing. We are dedicated to making bioproduction faster, more cost-effective and environmentally friendly than traditional chemical manufacturing and fermentation-based processes. Enzymit provides the missing technological link, developing tailor-made new-to-nature enzymes that can unlock any desired chemical reaction, at costs that rival existing technologies in an environmentally friendly manner. Prior to joining Enzymit, Itay worked as a research scientist for several biotech startups. We are ushering in a new era of bio production through the creation of novel enzymes that address unmet market needs. As the world’s population grows and resources are in greater demand than ever before, an alternative to outdated, pollution-producing chemical manufacturing is required to meet humanity’s needs. Today, bioproduction relies primarily on fermentation, which entails significant complexities, lengthy development time, and high capital costs. Coined the next industrial revolution, biomanufacturing has been talked about for decades but has yet to be fully realized.